GlassScriptPhysician profile
Claudia Iveth Stclair
NPI 1750991741
$1,680.41
in general payments reported to CMS, 2019-2025
7 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $170 · 2024: $1,341 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $883 · Food and Beverage: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $883.42 |
| Food and Beverage | $796.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,079.85 | 2024 | Linq II, Hawkone, Spiderfx |
| Shockwave Medical, INC | $216.06 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $181.61 | 2023-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $88.60 | 2023 | Verquvo |
| Stryker Corporation | $60.58 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Philips North America LLC | $35.39 | 2023-2024 | (Ck4) Mcot |
| Amgen INC. | $18.32 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudia Stclair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.